Moncton is at the centre of a growing substance use crisis in New Brunswick. Overdose deaths in the city have risen in recent years, with fentanyl increasingly identified as a driver of fatal incidents. In 2024 alone, New Brunswick recorded 78 apparent opioid toxicity deaths — and Moncton, as the province’s largest and fastest-growing city, bears a disproportionate share of that burden. In the first half of 2024, naloxone was administered to an average of 53 opioid overdose patients per month across the province, according to Ambulance New Brunswick.
Beyond opioids, alcohol, cocaine, benzodiazepines, and prescription drug misuse affect thousands of Moncton residents each year — cutting across income levels, neighbourhoods, and backgrounds. Moncton’s rapid population growth, its role as an economic hub for the Maritimes, and the pressures of urban life have created conditions where addiction can take hold quickly and quietly.
The public system is under severe strain. New Brunswick’s auditor general reported in December 2024 that more than half of patients classified as high priority for addiction and mental health care waited longer than the provincial government’s own 14-day target — and for residential treatment specifically, some New Brunswickers have faced waits of three to eight months. The window when someone is ready and willing to seek help is fragile. Private treatment allows you to act on it immediately.